Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
Inan, but for you and a few other posters on here the majority of us would be completely in the dark and I am grateful for your input. The isue remains that the the company is utterly useless at the PR side of the business. RNSs are blunt and to the point when a little bit of story telling would help everyone, especially people who have not been in this share for ages. There are lots of questions that a newbie would ask that could be included in RNSs : Why are there now multiple platforms? Where do they overlap? Why do we need them? Which is the priority? How will they be monitised?
And so on. No one doubts the science, but are you confident there is the expertise to ensure the shareholders get full benefit for their patience? You might imagine a cure for cancer would be an easy sell, but the reality seems to be proving more difficult. Is there an inherent problem with the science that puts others off, or is it just that the BoD can't pitch a deal and see it through to closure?
Or maybe a dump and dump operation. To be honest I am starting to be concerned about my investment here. I have been here for the better part of 5 years working on the assumption that a company on the brink of a cure for cancer would be a fantatic investment. It never occured to me that this company would be so well run on the science side and yet so hapless on the business aspects of what needs to be done. Essentially I have been chasing a falling share price since day one. Its now time for the company to realise that they need to embrace some serious PR and stop treating investors like the proverbial mushrooms. Even a simple road map and occasional newsletter to keep us in the loop would be better than the current wall of silence on the business opportunities. Its been 12 months since the collabration with BioNtech started, how is it progressing? Is the FDA submission back on track? Will we get 2 trials started this year? Surely if there is to be yet another cash raise, its better done at 15p than 5p?
Pull your fingers out and get a deal over the line for crying out loud. This is painful.
No need to get all defensive! The point is this cosy echo chamber doesn't get out to the wider audience that this company needs. I have no doubt that you understand what's happening with the science and thanks to you I know more about it than many but there are millions who have never even heard of Scancell, and that's a problem for the BoD to solve and I for one wish they would do so quickly and effectively.
that someone from the company would, in very simple terms lay out exactly what the company is working on, what they are creating and why what they have already created is important and where it is all leading to. A roadmap and a loose timeline would help potential investors realise what is going on behind what seem to be very tightly shut doors.
The current share price cannot be regarded as a particularly good thing by anyone, it may well present an opportunity to buy more as I did last week, but is all this brilliant science really only worth £30m? It would cost another company £100s of millions to reach Scancell's position and yet here we are, apparently unloved by investors and uninvestable by the industry.
It's great that they are so busy in the labs, but surely it's time for someone to start taking the share price seriously and to start telling the Scancell story to a much wider audience albeit in simplified terms that layman investors, journalists and broadcasters can easily get to grips with?
I had hoped that the GC would be a vehicle for getting the Scancell story into the press, but failing that the company needs to get stuck in. A £30m MC is pitiful and needs someone's attention PDQ. I have been here for 5 years now and am in for the long haul, assuming old age doesn't see me off first but jeez, it would be nice to see some patches of blue sky now.
I think Alexa might have missed out the compounding effect Ian B, if today is 100% tomorrow will 103%, the day after will be 103+3% and so on, I think that gives 68p at 3% daily and 106p at 5% but I will be happy with the figures Alexa arrived at.
There are batteries available for homes that have solar panels, currently costing £4-5k . Assuming the developments in solar technology continue, then the opportunity to save the power generated during the day and use it at night will be huge. It seems likely that Graphene will be a significant part of both solar panel development and battery storage. Its not a huge leap to imagine every lamp post with a panel and a battery, especially now that LED bulbs are becoming the norm. Tesla is one of the leading providers of household batteries and have also developed roof tiles that act as solar panels, couple all this with storage that happens in seconds and minutes rather than hours and the energy world changes.
Max, you need to chill out a little, you have been banging the anti - brexit drum for weeks now and we are still leaving in March . I have no idea why you think invoking memories of 1945 - 1949 is likely to influence the situation, the simple fact is we joined because politicians lied to us about the common market and politicians are still lying to us about the EU. Being confined politically and economically within a super state that has been effectively asset stripping us for nearly 50 years is not an attractive proposition and many of us will be happy to leave under almost any circumstances. Mainly so that we can regain control of our destiny and of those who would plough the UK into the ground with the support of the unelected EU bureaucrats. Having spent half a lifetime in international sales I can assure you that if the UK seizes the opportunity presented by Brexit with both hands we will be absolutely fine. The EU project will not last another Decade
Interesting Article:
http://blog.gorozen.com/blog/how-the-electrification-of-india-may-impact-copper-prices
Hi Max, I am fairly sure the RNS refers to "aircraft interior parts" I am not sure we can assume it refers just to covers or linings of seats. It could be that they want to build the overhead lockers, seat skeletons, seat-back tables and or a host of other elements from the passenger cabin using a Nanene impregnated substance. Clearly some of the intended material has been tested for its fire re tardent properties as you might expect, but my guess is that the "major airline" is looking at more than seat covers which are already highly proofed against fire and to which Nanene may not add much additional benefit.
I would have thought that the main purpose of introducing Nanene would be for the potential weight-saving properties rather than the fire-proofing. Less weight equals less fuel equals more profit and a serious consideration for every company flying passenger aircraft. Equally military aircraft capable of being lighter and yet stronger would be a big advantage. Obviously fire resistance is a big feature but it is the weight saving that will drive sales.
Bearing in mind a tonne of few-layer Nanene would require 38000 barrels to ship it, opening production plants in other parts of the world is the only realistic way of developing sufficient sales volume to attain the maximum potential of this brilliant product. So if keeping the IP under lock and key in the UK isn't possible then some sort of deal will have to be done to permit production in China and other legislations. It seems like a minor problem compared to the upside of world-wide production and sales. Surely building tamper proof machines and producing cast iron contracts cant be that hard?
that this is the last throw of the dice for whoever wants to keep the price down at these levels. They know that news is on its way and that the longest tree shake in history is coming to an end. They even threw Patch007 at it to try and shake a few out. this down-trend has been going on all year and the last gasp desperation is beginning to show, but we know and they know it can't go on much longer. Holding tight. The darkest hour is just before dawn.!
Nothing new but better than a poke in the eye with a pointed stick!
https://www.gbreports.com/interview/vincent-mascolo
Is there anyone left here? Did you all sell up and not tell me? Don't tell me you all fell for that prat on twitter who keeps predicting the end of Graphene as we know it? You know him, the one who wants to know the details of every single order that arrives and can't see any point in investing in rapid charge batteries that will change the world?
I did say "if necessary". The imperative is to prove the drugs work in humans, If the latest trigrid device is OK in Europe, fine, get on with trialing wherever you can get the clinics. If the US eventually gives the go ahead, it may be that the European results will be sufficiently good to get someone else to pay for US trials. If scib and modi are as good as we think they are, , eventually we will get bought out for the sort of money we all dream about, but we wont know until some sort of trials happen.Better to shoot and then adjust your aim than spend your time aiming and find out your sights need adjusting.. O f course , I guess the way forward now is in the hands of the FDA , we dont know how long this isue might take to resolve, if its weks not too big a problem, but if its months....?
And therein may well be the reason for the FDA delaying the trial, particularly bearing in mind we are not a US Company. Personally I would do the trial in the UK, using the old device if neccessary, and find out if it works as expected as quickly as possible. If it does work, the Big Pharma will be flocking to the UK to get their hands on it. The US has been a distraction for too long we should cut our losses there and concentrate on getting Modi 1 and 2 and scib 2 into the clinic in the UK. Easier to control, better for the share price and quicker to put into effect and much easier to get the press coverage required.
Well, they have taken big chunks out of everything else in my portfolio so I see no reason why this share should be any different. Funny really as I was only thinking on Monday that SCLP seemed to be escaping without too much damage ... Oh well onwards and upwards!
"After all, who wants to sell a product to a company whose currency is devaluing ensuring they loose money. "
Able, isn't the whole point of Letters of Credit to protect the exporter against the vagaries of currency fluctuations or the collapse of the company you are working with? Whenever I exported I insisted on payment in Pounds and my contracts insisted that UK law would be the final arbiter, surely any savvy exporter with people from DIT working for them will be capable of setting up a deal that ensures they are not left holding the baby if the importer or his currency goes elbows up? A LoC costs as little as 0.125% of the value of the deal and is generally regarded as a cost of exporting. Given the potential price of Nanene and the machines that make it, its peanuts.